Single-Use Bioreactors

Chapter Outlines

Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the single-use bioreactors market and its likely evolution in the short to mid-term and long term.

Chapter 3 provides a general introduction to single-use bioreactors, covering details related to the current and future trends in the domain. Further, it includes a comparison between the conventional stainless-steel bioreactor and single use bioreactor. The chapter also highlights the different types of cell cultures, agitation mechanisms and areas of application for single-use bioreactors. In addition, it also elaborates on the prevalent regulatory standards, current needs and advantages of single-use bioreactors.

Chapter 4 includes information on 160 single-use bioreactors that are either commercialized or under development. It features detailed assessment of the overall market landscape of single-use bioreactors based on a number of relevant parameters, such as status of development (commercially available and under development), type of single-use bioreactor (stirred tank, pneumatically mixed, rocker / rotating, wave-induced, paddle sleeve, fixed-bed, hollow fiber, diffusion, orbitally shaken, and others), scale of operation (laboratory scale, pilot scale, and large scale), area of application (cancer research, drug discovery / toxicology testing, stem cell research, tissue engineering / regenerative medicine, and others), typical working volume, weight of the bioreactor, stirrer speed, cell culture system (mammalian, insect, microbial, viral, plant, bacterial, and others), and type of molecule (vaccine, monoclonal antibody, recombinant protein, stem cell, cell therapy, gene therapy, and others). In addition, it presents details of the companies manufacturing single-use bioreactors, highlighting their year of establishment, size of employee base, and geographical presence.
 
Chapter 5 includes a contemporary market trend analysis, which include [A] a tree map, comparing the type of single-use bioreactor and company size, [B] an insightful grid representation based on scale of operation, area of application and type of cell culture, [C] heat map representation analyzing type of single-use bioreactor and area of application, and [D] a world map representation highlighting the regional distribution of players based on the location of headquarters.

Chapter 6 features elaborate profiles of prominent players (shortlisted based on number of products being offered) engaged in the development of single-use bioreactors. Each company profile features a brief overview of the company, along with information on year of establishment, number of employees, location of headquarters and key members of the executive team. It also includes details of their respective product portfolio, and recent developments and an informed future outlook.

Chapter 7 features an analysis of the various partnerships related to single-use bioreactors, which have been established till September 2020, based on several parameters, such as year of agreement, type of partnership (full business acquisition, product / technology development agreement, product / technology integration agreement, product distribution / marketing agreement, product portfolio acquisition, service alliance, and supply agreement), focus area (expansion / upgrade of manufacturing facility, incorporation of automation solutions, product development / testing, product maintenance, product portfolio expansion, supply of cell media products / equipment), and most active players. It also provides the regional distribution of the players involved in the collaborations.

Chapter 8 features a detailed competitiveness analysis of single-use bioreactors, taking into consideration several relevant parameters, such as the supplier power (based on expertise of the manufacturer) and key product-related specifications, including status of development, working volume, stirrer speed, weight of the product, scale of operation, type of cell culture, type of molecule, and area(s) of application.

Chapter 9 features an insightful three-dimensional bubble chart representation, highlighting the competitiveness analysis of single-use bioreactor manufacturers, taking into consideration the supplier power (based on expertise of the manufacturer), product portfolio strength, portfolio diversity, and number of area(s) of application.

Chapter 10 features a detailed brand positioning analysis of the key industry players, highlighting the current perceptions regarding their proprietary products by taking into consideration several relevant aspects, such as the experience of a manufacturers, number of products offered, product diversity, number of area(s) of application, number of patents and partnerships inked. 

Chapter 11 provides an in-depth patent analysis presenting an overview of how the industry is evolving from the R&D perspective. For this analysis, we considered of over 2,800 patents that have been filed / granted for single-use bioreactors, between 1995 and 2020 (till September), highlighting key trends associated with these patents, across type of patents, publication year, issuing authorities involved, emerging focus area, patent age, CPC symbols, leading patent assignees (in terms of number of patents granted / filed), patent characteristics and geography. It also includes a detailed patent benchmarking and an insightful valuation analysis. 

Chapter 12 features an insightful market forecast analysis, highlighting the likely growth of the single-use bioreactors market, for the time period 2020-2030. In order to provide details on the future outlook, our projections have been segmented on the basis of [A] type of cell culture system (mammalian, insect, microbial, viral, plant, bacterial, and others), [B] type of molecule (vaccines, monoclonal antibodies, recombinant proteins, stem cells, cell therapies, gene therapies, and others), [C] area of application (cancer research, drug discovery /  toxicology testing, stem cell research, and tissue engineering / regenerative medicine), [D] scale of operation (small scale, large scale), [E] purpose (R&D and manufacturing), [F] end-user (biopharmaceutical / pharmaceutical industries and academic / research institutes), and [G] key geographical regions (North America, Europe, Asia-Pacific, Latin America, MENA (Middle East and North Africa) and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.

Chapter 13 presents a case study, including the key technological innovations, such as built-in system control sensors, advanced alarm systems, electronic-log records, touch screens, real-time tracking, remote monitoring, and advanced mixing technologies in the single-use bioreactors industry.

Chapter 14 provides a detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution, including a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall single-use bioreactors industry.

Chapter 15 is a summary of the entire report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.

Chapter 16 is a collection of interview transcripts of discussions held with various key stakeholders in this market. The chapter provides a brief overview of the companies and details of interviews held with Per Stobbe (Chief Executive Officer, Marketing, Technical Support, CerCell), and Torsten Due Bryld (Chief Commercial Officer, CelVivo).

Chapter 17 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 18 is an appendix, which contains the list of companies and organizations mentioned in the report.

Chapter 19 is an appendix, which contains an indicative list of business offering accessories, media bags, equipment, and automation solutions for single-use bioreactors.

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION 
3.1. Chapter Overview
3.2. Overview of Single Use-Bioreactors 
3.2.1. Historical Evolution
3.2.2. Single-Use vs Traditional Bioreactors

3.3. Types of Single-Use Bioreactors 
3.3.1. Based on Cell Culture
3.3.2. Based on Agitation Mechanism

3.4. Advantages of Single-Use Bioreactors 
3.5. Challenges Associated with Single-Use Bioreactors 
3.6. Key Applications Areas 
3.7. Prevalent Regulatory Standards
3.8. Future Prospects 

4. MARKET LANDSCAPE 
4.1. Chapter Overview
4.2. Single-Use Bioreactors: Overall Market Landscape
4.2.1. Analysis by Status of Development
4.2.2. Analysis by Type of Single-Use Bioreactor
4.2.3. Analysis by Scale of Operation

4.2.4. Analysis by Area of Application
4.2.5. Analysis by Working Volume 
4.2.6. Analysis by Weight of Bioreactor 
4.2.7. Analysis by Stirrer Speed
4.2.8. Analysis by Type of Cell Culture Handled
4.2.9. Analysis by Type of Molecule

4.3. Single-Use Bioreactor Manufacturers: Overall Market Landscape
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters

4.4. Leading Manufacturers: Analysis by Number of Products

5. KEY INSIGHTS
5.1. Chapter Overview
5.2. Tree Map Representation: Analysis by Type of Single-Use Bioreactor and Company Size
5.3. Grid Representation: Analysis by Scale of Operation, Area of Application and Type of Cell Culture
5.4. Heat Map Representation: Analysis by Type of Single-Use Bioreactor and Area of Application
5.5. World Map Representation: Analysis by Location of Headquarters 

6. COMPANY PROFILES
6.1. Chapter Overview

6.2. Leading Players based in North America
6.2.1. Celartia
6.2.1.1. Company Overview
6.2.1.2. Product Portfolio
6.2.1.3. Recent Developments and Future Outlook

6.2.2. Cell Culture Company
6.2.2.1. Company Overview
6.2.2.2. Product Portfolio
6.2.2.3. Recent Developments and Future Outlook

6.2.3. Cytiva
6.2.3.1. Company Overview
6.2.3.2. Product Portfolio
6.2.3.3. Recent Developments and Future Outlook

6.2.4. Merck Millipore
6.2.4.1. Company Overview
6.2.4.2. Product Portfolio
6.2.4.3. Recent Developments and Future Outlook

6.2.5. Pall Corporation
6.2.5.1. Company Overview
6.2.5.2. Product Portfolio
6.2.5.3. Recent Developments and Future Outlook

6.2.6. PBS Biotech
6.2.6.1. Company Overview
6.2.6.2. Product Portfolio
6.2.6.3. Recent Developments and Future Outlook

6.2.7. Synthecon
6.2.7.1. Company Overview
6.2.7.2. Product Portfolio
6.2.7.3. Recent Developments and Future Outlook

6.2.8. Thermo Fisher Scientific
6.2.8.1. Company Overview
6.2.8.2. Product Portfolio
6.2.8.3. Recent Developments and Future Outlook

6.3. Leading Players based in Europe
6.3.1. Cellexus
6.3.1.1. Company Overview
6.3.1.2. Product Portfolio
6.3.1.3. Recent Developments and Future Outlook

6.3.2. CerCell
6.3.2.1. Company Overview
6.3.2.2. Product Portfolio
6.3.2.3. Recent Developments and Future Outlook

6.3.3. Eppendorf
6.3.3.1. Company Overview
6.3.3.2. Product Portfolio
6.3.3.3. Recent Developments and Future Outlook

6.3.4. Pierre Guerin
6.3.4.1. Company Overview
6.3.4.2. Product Portfolio
6.3.4.3. Recent Developments and Future Outlook

6.3.5. ProlifeCell
6.3.5.1. Company Overview
6.3.5.2. Product Portfolio
6.3.5.3. Recent Developments and Future Outlook

6.3.6. Sartorius Stedim Biotech
6.3.6.1. Company Overview
6.3.6.2. Product Portfolio
6.3.6.3. Recent Developments and Future Outlook

6.3.7. Solaris Biotech
6.3.7.1. Company Overview
6.3.7.2. Product Portfolio
6.3.7.3. Recent Developments and Future Outlook

6.4. Leading Players based in Asia-Pacific and Rest of the World
6.4.1. CESCO Bioengineering
6.4.1.1. Company Overview
6.4.1.2. Product Portfolio
6.4.1.3. Recent Developments and Future Outlook

7. PARTNERSHIPS AND COLLABORATIONS
7.1. Chapter Overview
7.2. Partnership Models

7.3. Single-Use Bioreactors: Recent Partnerships and Collaborations 
7.3.1. Analysis by Year of Partnership
7.3.2. Analysis by Type of Partnership
7.3.2.1. Analysis by Year of Partnership and Type of Partnership
7.3.2.2. Analysis by Company Size and Type of Partnership

7.3.3. Analysis by Focus Area
7.3.3.1. Analysis by Year of Partnership and Focus Area

7.3.4. Analysis by Type of Partner
7.3.4.1. Analysis by Year of Partnership and Type of Partner
7.3.4.2. Analysis by Type of Partnership and Type of Partner

7.3.5. Most Active Players: Analysis by Number of Partnerships
7.3.6. Regional Analysis
7.3.6.1. Intercontinental and Intracontinental Agreements

8. PRODUCT COMPETITIVENESS ANALYSIS
8.1. Chapter Overview
8.2. Methodology 
8.3. Assumptions / Key Parameters
8.4. Product Competitiveness Analysis: Stirred Tank Single-Use Bioreactors
8.5. Product Competitiveness Analysis: Pneumatically Mixed Single-Use Bioreactors
8.6. Product Competitiveness Analysis: Wave-Induced Single-Use Bioreactors
8.7. Product Competitiveness Analysis: Paddle Sleeve Single-Use Bioreactors
8.8. Product Competitiveness Analysis: Other Types of Single-Use Bioreactors

9. COMPANY COMPETITIVENESS ANALYSIS
9.1. Chapter Overview
9.2. Methodology 
9.3. Assumptions / Key Parameters

9.4. Competitiveness Analysis: Single-Use Bioreactor Manufacturers
9.5. Competitiveness Analysis: Companies Developing Stirred Tank Single-Use Bioreactor Manufacturers
9.6. Competitiveness Analysis: Companies Developing Pneumatically Mixed Single-Use Bioreactor Manufacturers
9.7. Competitiveness Analysis: Companies Developing Wave-Induced Single-Use Bioreactor Manufacturers
9.8. Competitiveness Analysis: Companies Developing Other Types of Single-Use Bioreactor Manufacturers

9.9. Competitiveness Analysis: Benchmarking of Top 10 Players

10. BRAND POSITIONING ANALYSIS 
10.1. Chapter Overview
10.2. Key Parameters and Methodology
10.3. Brand Positioning Matrix: Cytiva
10.4. Brand Positioning Matrix: Eppendorf
10.5. Brand Positioning Matrix: Merck Millipore
10.6. Brand Positioning Matrix: Pall Corporation
10.7. Brand Positioning Matrix: Pierre Guerin
10.8. Brand Positioning Matrix: Sartorius Stedim Biotech
10.9. Brand Positioning Matrix: Thermo Fisher Scientific

11. PATENT ANALYSIS 
11.1. Chapter Overview
11.2. Scope and Methodology

11.3. Single-Use Bioreactors: Patent Analysis
11.3.1. Analysis by Type of Patent
11.3.2. Analysis by Publication Year
11.3.3. Analysis by Granted Patents
11.3.4. Analysis by Year-wise Filed Patent Applications
11.3.5. Analysis by Issuing Authority
11.3.6. Analysis by Patent Focus
11.3.7. Analysis by Patent Age
11.3.8. Analysis by CPC Symbols
11.3.9. Analysis by Type of Applicant
11.3.10. Leading Players: Analysis by Number of Patents

11.4. Single-Use Bioreactors: Patent Benchmarking Analysis
11.4.1. Analysis by Patent Characteristics

11.5. Single-Use Bioreactors: Patent Valuation Analysis

12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Impact of COVID-19 Pandemic on Single-Use Bioreactors Market
12.4. Global Single-Use Bioreactors Market, 2020-2030

12.5. Global Single-Use Bioreactors Market: Distribution by Type of Cell Culture
12.5.1. Single-Use Bioreactors Market for Bacterial Cell Cultures, 2020-2030
12.5.2. Single-Use Bioreactors Market for Insect Cell Cultures, 2020-2030
12.5.3. Single-Use Bioreactors Market for Mammalian Cell Cultures, 2020-2030
12.5.4. Single-Use Bioreactors Market for Microbial Cell Cultures, 2020-2030
12.5.5. Single-Use Bioreactors Market for Plant Cell Cultures, 2020-2030
12.5.6. Single-Use Bioreactors Market for Viral Cell Cultures, 2020-2030
12.5.7. Single-Use Bioreactors Market for Other Cell Cultures, 2020-2030

12.6. Global Single-Use Bioreactors Market: Distribution by Type of Molecule
12.6.1. Single-Use Bioreactors Market for Cell Therapies 2020-2030
12.6.2. Single-Use Bioreactors Market for Gene Therapies, 2020-2030
12.6.3. Single-Use Bioreactors Market for Monoclonal Antibodies, 2020-2030
12.6.4. Single-Use Bioreactors Market for Recombinant Proteins, 2020-2030
12.6.5. Single-Use Bioreactors Market for Stem Cell Therapies, 2020-2030
12.6.6. Single-Use Bioreactors Market for Vaccines, 2020-2030
12.6.7. Single-Use Bioreactors Market for Other Molecules, 2020-2030

12.7. Global Single-Use Bioreactors Market: Distribution by Area of Application
12.7.1. Single-Use Bioreactors Market for Cancer Research, 2020-2030
12.7.2. Single-Use Bioreactors Market for Drug Discovery / Toxicity Testing, 2020-2030
12.7.3 Single-Use Bioreactors Market for Regenerative Medicine / Tissue Engineering, 2020-2030
12.7.4. Single-Use Bioreactors Market for Stem Cell Research, 2020-2030
12.7.5. Single-Use Bioreactors Market for Other Application Areas, 2020-2030

12.8. Global Single-Use Bioreactors Market: Distribution by Scale of Operation
12.8.1. Single-Use Bioreactors Market for Small Scale Operations, 2020-2030
12.8.2. Single-Use Bioreactors Market for Large Scale Operations, 2020-2030

12.9. Global Single-Use Bioreactors Market: Distribution by Purpose
12.9.1. Single-Use Bioreactors Market for Research and Development, 2020-2030
12.9.2. Single-Use Bioreactors Market for Biopharmaceutical Manufacturing, 2020-2030

12.10. Global Single-Use Bioreactors Market: Distribution by End-User
12.10.1. Single-Use Bioreactors Market for Biopharmaceutical / Pharmaceutical Industries, 2020-2030
12.10.2. Single-Use Bioreactors Market for Academic / Research Institutes, 2020-2030

12.11. Global Single-Use Bioreactors Market: Distribution by Key Geographical 
12.11.1. Single-Use Bioreactors Market in North America, 2020-2030
12.11.2 Single-Use Bioreactors Market in Europe, 2020-2030
12.11.3. Single-Use Bioreactors Market in Asia-Pacific, 2020-2030
12.11.4. Single-Use Bioreactors Market in Latin America, 2020-2030
12.11.5. Single-Use Bioreactors Market in Middle East and North Africa (MENA), 2020-2030
12.11.6. Single-Use Bioreactors Market in Rest of the World, 2020-2030

12.12. Concluding Remarks

13. CASE STUDY: KEY TECHNOLOGICAL INNOVATIONS IN THE SINGLE-USE BIOREACTORS INDUSTRY
13.1. Chapter Overview
13.2. Innovations in Bioreactor Display / Control Features
13.2.1. Built-in System Control Sensors
13.2.2. Advanced Alarm Systems
13.2.3. Electronic-Log Records and Touch Screens
13.2.4. Real-Time Tracking and Remote Monitoring
13.3. Innovation in Mixing Technologies
13.4. Concluding Remarks

14. SWOT ANALYSIS
14.1. Chapter Overview
14.2. Strengths
14.3. Weaknesses
14.4. Opportunities
14.5. Threats
14.6. Comparison of SWOT Factors

15. CONCLUSION

16. EXECUTIVE INSIGHTS
16.1. Chapter Overview
16.2. CerCell
16.2.1. Company Snapshot
16.2.2. Interview Transcript: Per Stobbe, CEO, Marketing, Technical Support

16.3. CelVivo 
16.3.1. Company Snapshot
16.3.2. Interview Transcript: Torsten Due Bryld, Chief Commercial Officer

17. APPENDIX I: TABULATED DATA

18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

19. APPENDIX III: LIST OF BUSINESSES OFFERING ACCESSORIES, EQUIPMENT, AND AUTOMATION SOLUTIONS

List Of Figures

Figure 3.1 Major Historical Events related to the Development of Single-Use Bioreactors
Figure 3.2 Conventional, Stainless Steel Bioreactors and Single-Use Bioreactors: Energy Consumption (Mega Joules)
Figure 3.3 Conventional, Stainless Steel Bioreactors and Single-Use Bioreactors: Water Consumption (Kilo Litres)
Figure 3.4 Single-Use Bioreactors: Type of Cell Culture Handled
Figure 3.5 Advantages Offered by Single-Use Bioreactors
Figure 3.6 Application of Single-use Bioreactors
Figure 4.1 Single-Use Bioreactors: Distribution by Status of Development
Figure 4.2 Single-Use Bioreactors: Distribution by Type of Single-Use Bioreactor
Figure 4.3 Single-Use Bioreactors: Distribution by Scale of Operation
Figure 4.4 Single-Use Bioreactors: Distribution by Area of Application
Figure 4.5 Single-Use Bioreactors: Distribution by Working Volume
Figure 4.6 Single-Use Bioreactors: Distribution by Weight of Bioreactor
Figure 4.7 Single-Use Bioreactors: Distribution by Speed of Stirrer
Figure 4.8 Single-Use Bioreactors: Distribution by Type of Cell Culture Handled
Figure 4.9 Single-Use Bioreactors: Distribution by Type of Molecule
Figure 4.10 Single-Use Bioreactor Developers: Distribution by Year of Establishment
Figure 4.11 Single-Use Bioreactor Developers: Distribution by Company Size
Figure 4.12 Single-Use Bioreactor Developers: Distribution by Location of Headquarters
Figure 4.13 Leading Manufacturers: Distribution by Number of Products
Figure 5.1 Tree Map Representation: Distribution by Type of Single-Use Bioreactor and Company Size
Figure 5.2 Heat Map Representation: Distribution by Scale of Operation, Area of Application and Type of Cell Culture Handled
Figure 5.3 Heat Map Representation: Distribution by Type of Single-Use Bioreactor and Area of Application
Figure 5.4 World Map Representation: Distribution by Location of Headquarters
Figure 7.1 Partnerships and Collaborations: Cumulative Year-Wise Trend, 2015-9M 2020
Figure 7.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 7.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 7.4 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Figure 7.5 Partnerships and Collaborations: Distribution by Focus Area
Figure 7.6 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Figure 7.7 Partnerships and Collaborations: Distribution by Type of Partner
Figure 7.8 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Figure 7.9 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 7.10 Most Active Players: Distribution by Number of Partnerships
Figure 7.11 Partnerships and Collaborations: Regional Distribution
Figure 7.12 Partnerships and Collaborations: Country-Wise Distribution
Figure 7.13 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 8.1 Product Competitiveness Analysis: Stirred Tank Single-Use Bioreactors
Figure 8.2 Product Competitiveness Analysis: Pneumatically Mixed Single-Use Bioreactors
Figure 8.3 Product Competitiveness Analysis: Wave-Induced Single-Use Bioreactors
Figure 8.4 Product Competitiveness Analysis: Paddle Sleeve Single-Use Bioreactors
Figure 8.5 Product Competitiveness Analysis: Other Types of Single-Use Bioreactors
Figure 9.1 Competitiveness Analysis: Single-Use Bioreactor Manufacturers
Figure 9.2 Competitiveness Analysis: Companies Developing Stirred Tank Single-Use Bioreactors
Figure 9.3 Competitiveness Analysis: Companies Developing Pneumatically Mixed Single-Use Bioreactors
Figure 9.4 Competitiveness Analysis: Companies Developing Wave-Induced Single-Use Bioreactors
Figure 9.5 Competitiveness Analysis: Companies Developing Other Types of Single-Use Bioreactors
Figure 9.6 Competitiveness Analysis: Benchmarking of Top 10 Players
Figure 10.1 Brand Positioning Analysis of Key Industry Players: Competitive Advantage
Figure 10.2 Brand Positioning Analysis of Key Industry Players: Reasons to Believe
Figure 10.3 Brand Positioning Matrix: Cytiva
Figure 10.4 Brand Positioning Matrix: Eppendorf
Figure 10.5 Brand Positioning Matrix: Merck Millipore
Figure 10.6 Brand Positioning Matrix: Pall Corporation
Figure 10.7 Brand Positioning Matrix: Pierre Guerin
Figure 10.8 Brand Positioning Matrix: Sartorius Stedim Biotech
Figure 10.9 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 11.1 Patent Analysis: Distribution by Type of Patent
Figure 11.2 Patent Analysis: Cumulative Distribution by Publication Year, 2015 – 9M 2020
Figure 11.3 Patent Analysis: Distribution of Granted Patents by Publication Year, 2015-9M 2020
Figure 11.4 Patent Analysis: Distribution of Filed Patents by Publication Year, 2015-9M 2020
Figure 11.5 Patent Analysis: Distribution by Issuing Authority
Figure 11.6 Patent Analysis: Distribution by Patent Focus
Figure 11.7 Patent Analysis: Distribution by Patent Age
Figure 11.8 Patent Analysis: Distribution by CPC Symbols
Figure 11.9 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant (2015 - 9M 2020)
Figure 11.10 Leading Players Assignees (Industry Players): Distribution by Number of Patents
Figure 11.11 Leading Players Assignees (Non-Industry Players): Distribution by Number of Patents
Figure 11.12 Patent Analysis (Top 10 CPC Symbols): Benchmarking by Leading Players
Figure 11.13 Patent Valuation Analysis
Figure 12.1 Global Single-Use Bioreactors Market, 2020-2030 (USD Million)
Figure 12.2 Global Single-Use Bioreactors Market: Distribution by Type of Cell Culture Handled, 2020 and 2030
Figure 12.3 Single-Use Bioreactors Market for Bacterial Cell Cultures, 2020-2030 (USD Million)
Figure 12.4 Single-Use Bioreactors Market for Insect Cell Cultures, 2020-2030 (USD Million)
Figure 12.5 Single-Use Bioreactors Market for Mammalian Cell Cultures, 2020-2030 (USD Million)
Figure 12.6 Single-Use Bioreactors Market for Microbial Cell Cultures, 2020-2030 (USD Million)
Figure 12.7 Single-Use Bioreactors Market for Plant Cell Cultures, 2020-2030 (USD Million)
Figure 12.8 Single-Use Bioreactors Market for Viral Cell Cultures, 2020-2030 (USD Million)
Figure 12.9 Single-Use Bioreactors Market for Other Cell Cultures, 2020-2030 (USD Million)
Figure 12.10 Global Single-Use Bioreactors Market: Distribution by Type of Molecule, 2020 and 2030
Figure 12.11 Single-Use Bioreactors Market for Cell Therapies 2020-2030 (USD Million)
Figure 12.12 Single-Use Bioreactors Market for Gene Therapies, 2020-2030 (USD Million)
Figure 12.13 Single-Use Bioreactors Market for Monoclonal Antibodies, 2020-2030 (USD Million)
Figure 12.14 Single-Use Bioreactors Market for Recombinant Proteins, 2020-2030 (USD Million)
Figure 12.15 Single-Use Bioreactors Market for Stem Cell Therapies, 2020-2030 (USD Million)
Figure 12.16 Single-Use Bioreactors Market for Vaccines, 2020-2030 (USD Million)
Figure 12.17 Single-Use Bioreactors Market for Other Molecules, 2020-2030 (USD Million)
Figure 12.18 Global Single-Use Bioreactors Market: Distribution by Area of Application, 2020 and 2030
Figure 12.19 Single-Use Bioreactors Market for Cancer Research, 2020-2030 (USD Million)
Figure 12.20 Single-Use Bioreactors Market for Drug Discovery / Toxicity Testing, 2020-2030 (USD Million)
Figure 12.21 Single-Use Bioreactors Market for Regenerative Medicine / Tissue Engineering, 2020-2030 (USD Million)
Figure 12.22 Single-Use Bioreactors Market for Stem Cell Research, 2020-2030 (USD Million)
Figure 12.23 Single-Use Bioreactors Market for Other Application Areas, 2020-2030 (USD Million)
Figure 12.24 Global Single-Use Bioreactors Market: Distribution by Scale of Operation, 2020 and 2030
Figure 12.25 Single-Use Bioreactors Market for Small Scale Operations, 2020-2030 (USD Million)
Figure 12.26 Single-Use Bioreactors Market for Large Scale Operations, 2020-2030 (USD Million)
Figure 12.27 Global Single-Use Bioreactors Market: Distribution by Purpose, 2020 and 2030
Figure 12.28 Single-Use Bioreactors Market for Research and Development, 2020-2030 (USD Million)
Figure 12.29 Single-Use Bioreactors Market for Biopharmaceutical Manufacturing, 2020-2030 (USD Million)
Figure 12.30 Global Single-Use Bioreactors Market: Distribution by End-User, 2020 and 2030
Figure 12.31 Single-Use Bioreactors Market for Biopharmaceutical / Pharmaceutical Industries, 2020-2030 (USD Million)
Figure 12.32 Single-Use Bioreactors Market for Academic / Research Institutes, 2020-2030 (USD Million)
Figure 12.33 Global Single-Use Bioreactors Market: Distribution by Key Geographical Regions, 2020 and 2030
Figure 12.34 Single-Use Bioreactors Market in North America, 2020-2030 (USD Million)
Figure 12.35 Single-Use Bioreactors Market in Europe, 2020-2030 (USD Million)
Figure 12.36 Single-Use Bioreactors Market in Asia-Pacific, 2020-2030 (USD Million)
Figure 12.37 Single-Use Bioreactors Market in Latin America, 2020-2030 (USD Million)
Figure 12.38 Single-Use Bioreactors Market in Middle East and North Africa (MENA), 2020-2030 (USD Million)
Figure 12.39 Single-Use Bioreactors Market in Rest of the World, 2020-2030 (USD Million)
Figure 12.40 Single-Use Bioreactors Market: Conservative, Base and Optimistic Scenarios, 2020, 2025 and 2030 (USD Million)
Figure 14.1 Single-Use Bioreactors Market: SWOT Analysis
Figure 14.2 Comparison of SWOT Factors: Harvey Ball Analysis

List Of Tables 

Table 3.1 Comparison between Conventional and Single-Use Bioreactors
Table 4.1 Single-Use Bioreactors: Information on Status of Development, Type of Bioreactor and Scale of Operation
Table 4.2 Single-Use Bioreactors: Information on Working Volume, Stirrer Speed, and Weight, Length, Width, Height and Diameter of Bioreactor
Table 4.3 Single-Use Bioreactors: Information on Type of Cell Culture Handled
Table 4.4 Single-Use Bioreactors: Information on Type of Molecule
Table 4.5 Single-Use Bioreactors: Information on Area of Application and Advanced Display / Control Features
Table 4.6 Single-Use Bioreactors: List of Manufacturers
Table 6.1 Single-Use Bioreactors: List of Companies Profiled
Table 6.2 Celartia: Company Snapshot
Table 6.3 Celartia: Single-Use Bioreactors Focused Product Portfolio
Table 6.4 Cell Culture Company: Company Snapshot
Table 6.5 Cell Culture Company: Single-Use Bioreactors Focused Product Portfolio
Table 6.6 Cellexus: Company Snapshot
Table 6.7 Cellexus: Single-Use Bioreactors Focused Product Portfolio
Table 6.8 CerCell: Company Snapshot
Table 6.9 CerCell: Single-Use Bioreactors Focused Product Portfolio
Table 6.10 CerCell: Recent Developments and Future Outlook
Table 6.11 CESCO Bioengineering: Company Snapshot
Table 6.12 CESCO Bioengineering: Single-Use Bioreactors Focused Product Portfolio
Table 6.13 Cytiva: Company Snapshot
Table 6.14 Cytiva: Single-Use Bioreactors Focused Product Portfolio
Table 6.15 Eppendorf: Company Snapshot
Table 6.16 Eppendorf: Single-Use Bioreactors Focused Product Portfolio
Table 6.17 Eppendorf: Recent Developments and Future Outlook
Table 6.18 Merck Millipore: Company Snapshot
Table 6.19 Merck Millipore: Single-Use Bioreactors Focused Product Portfolio
Table 6.20 Merck Millipore: Recent Developments and Future Outlook
Table 6.21 Pall Corporation: Company Snapshot
Table 6.22 Pall Corporation: Single-Use Bioreactors Focused Product Portfolio
Table 6.23 Pall Corporation: Recent Developments and Future Outlook
Table 6.24 PBS Biotech: Company Snapshot
Table 6.25 PBS Biotech: Single-Use Bioreactors Focused Product Portfolio
Table 6.26 PBS Biotech: Recent Developments and Future Outlook
Table 6.27 Pierre Guerin: Company Snapshot
Table 6.28 Pierre Guerin: Single-Use Bioreactors Focused Product Portfolio
Table 6.29 ProlifeCell: Company Snapshot
Table 6.30 ProlifeCell: Single-Use Bioreactors Focused Product Portfolio
Table 6.31 ProlifeCell: Recent Developments and Future Outlook
Table 6.32 Sartorius Stedim Biotech: Company Snapshot
Table 6.33 Sartorius Stedim Biotech: Single-Use Bioreactors Focused Product Portfolio
Table 6.34 Sartorius Stedim Biotech: Recent Developments and Future Outlook
Table 6.35 Solaris Biotech: Company Snapshot
Table 6.36 Solaris Biotech: Single-Use Bioreactors Focused Product Portfolio
Table 6.37 Synthecon: Company Snapshot
Table 6.38 Synthecon: Single-Use Bioreactors Focused Product Portfolio
Table 6.39 Thermo Fisher Scientific: Company Snapshot
Table 6.40 Thermo Fisher Scientific: Single-Use Bioreactors Focused Product Portfolio
Table 6.41 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.1 Partnerships and Collaborations: Information on Year of Agreement, Partner, Type of Partnership Model, and Focus Area, Pre-2015 – 9M 2020
Table 7.2 Partnerships and Collaborations: Information on Type of Agreement (Region-wise and Continent-wise), Pre-2015 – 9M 2020
Table 11.1 Patent Analysis: Distribution by CPC Symbols
Table 11.2 Patent Analysis: Most Popular CPC Symbols
Table 11.3 Patent Analysis: List of Top CPC Symbols
Table 11.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 11.5 Leading patents: Distribution by Number of Citations (by Highest Relative Valuation)
Table 16.1 CerCell: Company Snapshot
Table 16.2 CelVivo: Company Snapshot
Table 17.1 Conventional, Stainless Steel Bioreactors and Single-Use Bioreactors: Energy Consumption (Mega Joules)
Table 17.2 Conventional, Stainless Steel Bioreactors and Single-Use Bioreactors: Water Consumption (Kilo Litres)
Table 17.3 Single-Use Bioreactors: Distribution by Status of Development
Table 17.4 Single-Use Bioreactors: Distribution by Type of Single-Use Bioreactor
Table 17.5 Single-Use Bioreactors: Distribution by Scale of Operation
Table 17.6 Single-Use Bioreactors: Distribution by Area of Application
Table 17.7 Single-Use Bioreactors: Distribution by Working Volume
Table 17.8 Single-Use Bioreactors: Distribution by Weight of Bioreactor
Table 17.9 Single-Use Bioreactors: Distribution by Speed of Stirrer
Table 17.10 Single-Use Bioreactors: Distribution by Type of Cell Culture Handled
Table 17.11 Single-Use Bioreactors: Distribution by Type of Molecule
Table 17.12 Single-Use Bioreactors: Distribution by Year of Establishment
Table 17.13 Single-Use Bioreactor Developers: Distribution by Company Size
Table 17.14 Single-Use Bioreactor Developers: Distribution by Location of Headquarters
Table 17.15 Single-Use Bioreactor Developers: Distribution by Number of Products
Table 17.16 Tree Map Representation: Distribution by Type of Single-Use Bioreactor and Company Size
Table 17.17 Heat Map Representation: Distribution by Scale of Operation, Area of Application and Type of Cell Culture Handled
Table 17.18 Heat Map Representation: Distribution by Type of Single-Use Bioreactor and Area of Application
Table 17.19 World Map Representation: Distribution by Location of Headquarters
Table 17.20 Partnerships and Collaborations: Cumulative Year-Wise Trend, 2015-9M 2020
Table 17.21 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.22 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 17.23 Partnerships and Collaborations: Distribution by Company Size and Type of Partnership
Table 17.24 Partnerships and Collaborations: Distribution by Focus Area
Table 17.25 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Table 17.26 Partnerships and Collaborations: Distribution by Type of Partner
Table 17.27 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partner
Table 17.28 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 17.29 Most Active Players: Distribution by Number of Partnerships
Table 17.30 Partnerships and Collaborations: Regional Distribution
Table 17.31 Partnerships and Collaborations: Country-Wise Distribution
Table 17.32 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 17.33 Patent Analysis: Distribution by Type of Patent
Table 17.34 Patent Analysis: Cumulative Distribution by Publication Year, 2015 – 9M 2020
Table 17.35 Patent Analysis: Distribution of Granted Patents by Publication Year, 2015-9M 2020
Table 17.36 Patent Analysis: Distribution of Filed Patents by Publication Year, 2015-9M 2020
Table 17.37 Patent Analysis: Distribution by Issuing Authority
Table 17.38 Patent Analysis: Distribution by Patent Age
Table 17.39 Patent Analysis: Distribution by CPC Symbols
Table 17.40 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant (2015-9M 2020)
Table 17.41 Leading Players Assignees (Industry Players): Distribution by Number of Patents
Table 17.42 Leading Players Assignees (Non-Industry Players): Distribution by Number of Patents
Table 17.43 Patent Valuation Analysis
Table 17.44 Global Single-Use Bioreactors Market, 2020-2030 (USD Million)
Table 17.45 Global Single-Use Bioreactors Market: Distribution by Type of Cell Culture, 2020 and 2030
Table 17.46 Single-Use Bioreactors Market for Bacterial Cell Cultures, 2020-2030 (USD Million)
Table 17.47 Single-Use Bioreactors Market for Insect Cell Cultures, 2020-2030 (USD Million)
Table 17.48 Single-Use Bioreactors Market for Mammalian Cell Cultures, 2020-2030 (USD Million)
Table 17.49 Single-Use Bioreactors Market for Microbial Cell Cultures, 2020-2030 (USD Million)
Table 17.50 Single-Use Bioreactors Market for Plant Cell Cultures, 2020-2030 (USD Million)
Table 17.51 Single-Use Bioreactors Market for Viral Cell Cultures, 2020-2030 (USD Million)
Table 17.52 Single-Use Bioreactors Market for Other Cell Cultures, 2020-2030 (USD Million)
Table 17.53 Global Single-Use Bioreactors Market: Distribution by Type of Molecule, 2020 and 2030
Table 17.54 Single-Use Bioreactors Market for Cell Therapies 2020-2030 (USD Million)
Table 17.55 Single-Use Bioreactors Market for Gene Therapies, 2020-2030 (USD Million)
Table 17.56 Single-Use Bioreactors Market for Monoclonal Antibodies, 2020-2030 (USD Million)
Table 17.57 Single-Use Bioreactors Market for Recombinant Proteins, 2020-2030 (USD Million)
Table 17.58 Single-Use Bioreactors Market for Stem Cell Therapies, 2020-2030 (USD Million)
Table 17.59 Single-Use Bioreactors Market for Vaccines, 2020-2030 (USD Million)
Table 17.60 Single-Use Bioreactors Market for Other Molecules, 2020-2030 (USD Million)
Table 17.61 Global Single-Use Bioreactors Market: Distribution by Area of Application, 2020 and 2030
Table 17.62 Single-Use Bioreactors Market for Cancer Research, 2020-2030 (USD Million)
Table 17.63 Single-Use Bioreactors Market for Drug Discovery / Toxicity Testing, 2020-2030 (USD Million)
Table 17.64 Single-Use Bioreactors Market for Regenerative Medicine / Tissue Engineering, 2020-2030 (USD Million)
Table 17.65 Single-Use Bioreactors Market for Stem Cell Research, 2020-2030 (USD Million)
Table 17.66 Single-Use Bioreactors Market for Other Application Areas, 2020-2030 (USD Million)
Table 17.67 Global Single-Use Bioreactors Market: Distribution by Scale of Operation, 2020 and 2030
Table 17.68 Single-Use Bioreactors Market for Small Scale Operations, 2020-2030 (USD Million)
Table 17.69 Single-Use Bioreactors Market for Large Scale Operations, 2020-2030 (USD Million)
Table 17.70 Global Single-Use Bioreactors Market: Distribution by Purpose, 2020 and 2030
Table 17.71 Single-Use Bioreactors Market for Research and Development, 2020-2030 (USD Million)
Table 17.72 Single-Use Bioreactors Market for Biopharmaceutical Manufacturing, 2020-2030 (USD Million)
Table 17.73 Global Single-Use Bioreactors Market: Distribution by End-User, 2020 and 2030
Table 17.74 Single-Use Bioreactors Market for Biopharmaceutical / Pharmaceutical Industries, 2020-2030 (USD Million)
Table 17.75 Single-Use Bioreactors Market for Academic / Research Institutes, 2020-2030 (USD Million)
Table 17.76 Global Single-Use Bioreactors Market: Distribution by Key Geographical Regions, 2020 and 2030
Table 17.77 Single-Use Bioreactors Market in North America, 2020-2030 (USD Million)
Table 17.78 Single-Use Bioreactors Market in Europe, 2020-2030 (USD Million)
Table 17.79 Single-Use Bioreactors Market in Asia-Pacific, 2020-2030 (USD Million)
Table 17.80 Single-Use Bioreactors Market in Latin America, 2020-2030 (USD Million)
Table 17.81 Single-Use Bioreactors Market in Middle East and North Africa (MENA), 2020-2030 (USD Million)
Table 17.82 Single-Use Bioreactors Market in Rest of the World, 2020-2030 (USD Million)
Table 17.83 Single-Use Bioreactors Market: Conservative, Base and Optimistic Scenarios, 2020, 2025 and 2030 (USD Million)

List Of Companies

The following companies / institutes / government bodies and organizations have been mentioned 

1. 3Dnamics
2. ABEC
3. ABL Europe
4. Abzena
5. Adello Biologics
6. Advanced Scientifics
7. AdvantaPure
8. Aetos Biologics
9. Alector
10. Applikon Biotechnology
11. Artelis
12. ARTeSYN Biosolutions
13. ATMI LifeSciences
14. Baxter International
15. Bayer Technology Services
16. bbi-biotech
17. B-CULTURE
18. Biobrain
19. BioInvent International
20. Biosan
21. Brammer Bio
22. Broadley-James
23. Catalent
24. Celartia
25. Cell Culture Company
26. Cellexus
27. Celltainer Biotech
28. CELLution Biotech
29. CelVivo
30. CerCell
31. CESCO Bioengineering
32. Charter Medical
33. Cobra Biologics
34. Commonwealth Serum Laboratories (CSL)
35. Cytiva
36. Dana-Farber Cancer Institute
37. Danaher
38. Distek
39. EirGenix
40. Emergent BioSolutions
41. Emerson
42. Eppendorf
43. Esco Aster
44. ExcellGene
45. Finesse
46. Freeline
47. G & G Technologies
48. Gallus BioPharmaceuticals
49. G-Con Manufacturing
50. GE Healthcare
51. Getinge
52. Hamilton
53. Hamilton Process Analytics
54. Hyclone Laboratories
55. Hynetic
56. Icahn School of Medicine at Mount Sinai
57. Infors HT
58. INTEGRA Biosciences
59. Integrity CMI
60. Invitrogen
61. Kuhner Shaker
62. Leland Stanford Junior University
63. LevTech Consulting
64. LFB Biomanufacturing
65. Lonza
66. Massachusetts Institute of Technology
67. MedImmune
68. Meissner Filtration Products
69. Merck Millipore
70. Merck Sharp & Dohme
71. NewAge Industries
72. New Brunswick Scientific
73. Nova Biomedical
74. OmniBRx Biotechnologies
75. Pall Corporation
76. Paragon Bioservices
77. Parker Hannifin
78. Passage Bio
79. PBS Biotech
80. PerfuseCell
81. Pierre Guerin
82. Polestar Technologies
83. Precision Biologics
84. Premas Biotech
85. PreSens Precision Sensing
86. Progenitor Cell Therapy
87. ProlifeCell
88. Protalix BioTherapeutics
89. RAUMEDIC
90. RealBio Technology
91. Refine Technology
92. Rentschler Biopharma
93. Repligen
94. ReproCell
95. RoosterBio
96. Rosemount
97. SAFC Biosciences
98. SaniSure
99. Sarepta Therapeutics
100. Sartorius Stedim Biotech
101. SATAKE MultiMix
102. Scinus Cell Expansion 
103. Siemens 
104. Solaris Biotech
105. Solida Biotech
106. State Key Laboratory of Experimental Hematology
107. Südpack Medica
108. Swiss Federal Institutes of Technology Lausanne (EPFL)
109. Synthecon
110. Tarom Applied Technologies
111. Texas Tech University Health Science Center
112. The Scripps Research Institute
113. The Texas A&M University System
114. The University of Alberta
115. Thermo Fisher Scientific
116. Triumvirate Environmental
117. Univercells
118. University of Brescia
119. University of California
120. University of Colorado Board of Regents
121. University of Florida
122. University of Milan
123. University Of Texas
124. University of Zurich
125. Vanderbilt University
126. Voyager Therapeutics
127. Wake Forest Institute for Regenerative Medicine
128. Wave Biotech
129. Wave Biotech (Based in Switzerland)
130. Whitehead Institute for Biomedical Research
131. WuXi Biologics
132. Xcellerex